Paylocity Holding (PCTY) surged approximately 31% over the past 30 days, climbing from $104.53 on June 30 to $136.71 at the July 30 close, driven by multiple positive catalysts. Over the last quarter, the stock gained roughly 30%, recovering from its 52-week low of $92.99 reached in early April 2026.

Price target in focus: $80 per share — a round-number psychological milestone roughly 9% above PBF Energy's latest closing price near $73. Strongest bullish factors: A massive Q2 2026 earnings beat ($6.22 EPS vs. $4.15 estimated), the successful restart of the Martinez refinery, rapidly improving refining margins, and aggressive debt reduction of over $1.4 billion.

PACS Group shares have risen approximately 6% over the last 30 days, pushing the stock near its 52-week high and extending a broader multi-month uptrend. The company operates 324 post-acute care facilities across 17 states, positioning it as one of the largest skilled nursing providers in the United States.

The $135 price target represents the highest Wall Street target for SYRE, set by Deutsche Bank, implying approximately 33% upside from the current price near $101.50. Strong bullish factors include a unanimous analyst consensus rating of Strong Buy, a broad pipeline targeting multi-billion-dollar IBD markets, and significant institutional ownership above 90%.

Target in Focus: The $50 price level represents a psychological milestone and sits near the upper range of Wall Street analyst price targets, which currently extend as high as $60. Merger Synergies: The January 2026 Civitas Resources merger has already unlocked approximately $185 million in cost synergies, with management targeting $200–$300 million and estimating up to $1.5 billion in total present value.

Price Target in Focus: Jack Henry & Associates (NASDAQ: JKHY ) closed at $154.24 on July 30, 2026, meaning a climb to $200 would require roughly a 30% gain from current levels. Bullish Catalysts: Record core banking wins, an expanding digital product suite, a Google Cloud AI partnership, and a depressed valuation relative to historical multiples all support the recovery narrative.

CRNX currently trades near $83.63, just below the $85 per-share cash acquisition price offered by Vertex Pharmaceuticals in July 2026. Reaching $90 would require a competing bid, a revised offer, or a deal-break scenario that unlocks standalone value above the current takeout price.

Full Truck Alliance Co. Ltd. (NYSE: YMM) closed at $9.56 on July 30, 2026, meaning a move to $12 would require a gain of approximately 25.5% from current levels. The consensus analyst price target sits near $12.59, with 14 of 16 covering analysts rating the stock a Buy or Strong Buy, suggesting Wall Street broadly sees $12 as achievable.

Bio-Techne shares rose approximately 1.5% over the last 30 days, trading near $72 as the stock hovers just below Merck KGaA's $73-per-share acquisition offer. The pending $11.3 billion all-cash acquisition by Merck KGaA, announced in late June 2026, has become the dominant force anchoring TECH's valuation and muting volatility.

Target in focus: GWRE closed at $153.21 on July 30, 2026, and the $200 level represents roughly 30% upside from current levels — a round-number psychological barrier that aligns closely with the lower end of Wall Street's consensus analyst price target range. Bullish fuel: Guidewire's cloud migration super-cycle continues to gather pace, with Annual Recurring Revenue (ARR) reaching $1.147 billion as of Q3 FY2026, up approximately 22% year-over-year, supported by major Tier-1 insurer wins and new AI-driven product launches.

Sonos shares plunged -17.64% during Thursday's regular trading session, closing at $14.43 after having risen +4.29% the prior day on an initial post-earnings pop. The sell-off came despite a Q3 FY2026 beat: revenue rose +9% YoY to $375.3M and adjusted EPS of $0.27 crushed the $0.02 loss estimate — a classic "sell the news" reversal.

Adjusted earnings per share (EPS) came in at $3.69, surpassing the consensus estimate of $3.49 by $0.20 and reflecting a 17.9% increase from $3.13 in the same quarter last year. Revenue reached $6.59 billion, edging past analyst expectations of $6.58 billion and representing year-over-year growth of 9.4%.

Revenue and EPS beat estimates: Anheuser-Busch InBev reported Q2 2026 revenue of $16.66 billion (up 5.6% organically) and underlying earnings per share of $1.21, topping consensus estimates of $16.39 billion and $1.12 respectively. Beer volumes returned to growth: Global beer volumes rose 1.1% in the quarter, marking a continuation of positive momentum, while total volumes increased 0.9% year over year.

Adjusted earnings surged to $9.84 billion , more than doubling the $4.26 billion reported in Q2 2025 and beating the company-provided analyst consensus of $8.92 billion. Cash flow from operations (CFFO) reached $21.4 billion , driven by higher realized commodity prices, a $3.4 billion working capital inflow, and strong trading performance.

Adjusted EPS of $5.04 surpassed the Wall Street consensus estimate of $4.77 by 5.7%, while net revenue of $9.28 billion beat the $9.06 billion forecast. Cross-border volume rose 12% on a local-currency basis, fueled by resilient travel spending and strong card-not-present transactions.

Amazon reported Q2 2026 revenue of $200.6 billion , up 20% year-over-year and comfortably above the consensus estimate of approximately $196.5 billion. Earnings per share (EPS) came in at $5.75 , far exceeding the analyst consensus of $1.82, boosted in part by a $53.4 billion pre-tax gain tied to Amazon's investment in AI startup Anthropic.

Revenue reached $109.4 billion, a June-quarter record and up 16% year over year, narrowly topping analyst expectations. Diluted earnings per share came in at $2.02, beating consensus estimates of $1.89 by a comfortable margin. The figure included $0.11 from tariff refunds.

Distributable earnings (DE) reached $1.55 billion ($0.66 per share) for the quarter, surpassing the consensus estimate of $0.63 per share. DE before realizations grew 7% year-over-year to $1.39 billion ($0.59 per share), driven by strength across asset management and wealth solutions.

PN shares skyrocketed +120.80% during Thursday's regular session, closing at $23.67 versus the prior session's $10.72 close. The surge was triggered by the company's announcement that it completed the acquisition of the remaining 56% equity stake in Nanjing Cesun Power Co., Ltd.

Revenue beat: Amazon reported $200.61 billion in net sales, up 19.6% year-over-year and ahead of the consensus estimate of approximately $197 billion. GAAP earnings surge: Earnings per share (EPS) came in at $5.75, far exceeding the $1.82 consensus, driven largely by a $53.4 billion non-operating gain linked to Amazon's investment in AI startup Anthropic.